Theravance Biopharma
TBPH
TBPH
83 hedge funds and large institutions have $425M invested in Theravance Biopharma in 2015 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 32 increasing their positions, 21 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding
Funds holding: 83 → 83 (0)
0% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 12
Holders
83
Holding in Top 10
2
Calls
$96K
Puts
$2K
Top Buyers
| 1 | +$77M | |
| 2 | +$27.4M | |
| 3 | +$2.2M | |
| 4 |
GAM
Gotham Asset Management
New York
|
+$733K |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$697K |
Top Sellers
| 1 | -$6.2M | |
| 2 | -$5.68M | |
| 3 | -$4.16M | |
| 4 |
RP
Reinhart Partners
Mequon,
Wisconsin
|
-$1.8M |
| 5 |
RA
Royce & Associates
New York
|
-$1.72M |